Effects of Pitavastatin Treatments on the Plasma Lgi3 Level in the Patients With Dyslipidemia
Status:
Completed
Trial end date:
2020-02-13
Target enrollment:
Participant gender:
Summary
Leucine-rich glioma inactivated 3(Lgi3) has been postulated to have a pro-inflammatory
adipokine that inter-plays with other adipokines in adipogenesis and metabolic inflammation
according to recent investigations. Thus, in this study, we sought to demonstrate that the
treatment of statin can decrease Lgi3 level along with the decrease of the atherosclerosis to
further evaluate the role of Lgi3 in atherosclerosis.